Levamlodipine/Telmisartan

左旋氨氯地平/替米沙坦

Report date: 2025/02/12 16:58:48

Base Information

Drug NameLevamlodipine/Telmisartan
Drug Alias Name替米沙坦/左旋氨氯地平Telmisartan/LevamlodipineS-amlodipine/telmisartanTelminuvo TabTelmisartan/S-amlodipine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated L-type calcium channel blockersAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Voltage-gated L-type calcium channel
Therapy Area/IndicationsDyslipidemiasHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2014/01/01
Country/TerritorySouth Korea
CombinationsYes TelmisartanLevamlodipine Maleate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesChong Kun Dang Pharmaceutical Corp
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsDyslipidemias

Other Information

ATC CodeC09DB04
Related LinksN/A